retatrutide update october 2025 TikTok influencers fuelling parallel market for unlicensed weight-loss drug | Consumer affairs Triple hormone receptor agonist retatrutide

Furthermore, typical side effects associated with the use of such drugs, including nausea and digestion problems, have resulted in an increased interest of consumers in products that do not cause discomfort and which are easily digestible, low on sugar and with controlled portions

The SELECT trial, completed in 2023 with over 17,600 participants, showed a 20% reduction in cardiovascular events in patients with established cardiovascular disease and overweight or obesity without diabetes

If you choose to drink, never drink on an empty stomach and monitor your blood sugar before, during, and after

The case demonstrates the intricate management required for GLP-1RA-induced hypersensitivity reactions while showing the critical need for tailored treatment strategies [48]

In California, new rules that took effect in October 2025 place an affirmative duty on you to verify and document a clinically significant difference for every patient

Segn los ensayos clnicos, Mounjaro es el medicamento ms eficaz ahora mismo tanto para el tratamiento de la diabetes como en la obesidad, mejores que los de Wegovy, indicado tambin para la diabetes y contra la obesidad, y que Ozempic, que solo est aprobado para la diabetes, aunque se haya extendido su uso tambin para perder peso